Kristin M. Abaonza

FDA investigator

Appears on 12 documents from 2015 to 2026, mostly at sites in California. Most often cites general requirements (21 CFR 211.160).

12
Documents on file
3.6
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 40 observations

Activity by year

2015: 1, 2016: 1, 2017: 3, 2018: 1, 2019: 3, 2024: 1, 2025: 1, 2026: 1

Where

California 6 · Washington 2 · Alaska 1 · Nevada 1

Is Kristin M. Abaonza coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 Ascendis Pharma LLCMar 6, 2026 · Palo Alto, California
483 BioEclipse Therapeutics, Inc.Mar 25, 2025
483 Shalini Iyengar, MBBSMay 24, 2024 · Hexham
483 Jubilant HollisterStier LLCJul 26, 2019 · Spokane, Washington
483 Jubilant HollisterStier, LLCJul 26, 2019 · Spokane, Washington
483 Geneva Woods Pharmacy, Inc. dba Geneva Woods PharmacyApr 9, 2019 · Anchorage, Alaska
483 White House Pharmacy Inc. dba San Jose Compounding PharmacySep 14, 2018 · San Jose, California

About this profile

What does Kristin M. Abaonza inspect?

Kristin M. Abaonza appears on 12 documents on file covering 11 sites, mostly in California.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.67 and 21 CFR 211.165(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kristin M. Abaonza is dated Mar 6, 2026.